The use of optogenetic strategies in biomedicine therapeutics has the potential to provide nonpharmacological modulation of nervous system function. The development of integrative, implantable, remote-powered devices is an advance towards translation of these strategies, with the potential for precision, revolutionary treatment of complex or refractory disease-related or trauma-related symptoms.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Mickle, A. D. et al. A wireless closed-loop system for optogenetic peripheral neuromodulation. Nature 565, 361–365 (2019).
Gonzalez, E. J. & Grill, W. M. Sensory pudendal nerve stimulation increases bladder capacity through sympathetic mechanisms in cyclophosphamide-induced cystitis rats. Neurourol. Urodyn. 38, 135–143 (2019).
Wenzel, B. J. et al. Detecting the onset of hyper-reflexive bladder contractions from the electrical activity of the pudendal nerve. IEEE Trans. Neural Syst. Rehabil. Eng. 13, 428–435 (2005).
Rutter, E. M. et al. Detection of bladder contractions from the activity of the external urethral sphincter in rats using sparse regression. IEEE Trans. Neural Syst. Rehabil. Eng. 26, 1636–1644 (2018).
Mattis, J. et al. Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat. Methods 9, 159–172 (2011).
Raimondo, J. V. et al. Optogenetic silencing strategies differ in their effects on inhibitory synaptic transmission. Nat. Neurosci. 15, 1102–1104 (2012).
DeBerry, J. J. et al. Differential regulation of bladder pain and voiding function by sensory afferent populations revealed by selective optogenetic activation. Front. Integr. Neurosci. 12, 5 (2018).
Maggi, C. A. et al. Cyclophosphamide cystitis in rats: involvement of capsaicin- sensitive primary afferents. J. Auton. Nerv. Syst. 38, 201–208 (1992).
Ma, X. L. et al. Experimental evidence for alleviating nociceptive hypersensitivity by single application of capsaicin. Mol. Pain 11, 22–31 (2015).
Samineni, V. K. et al. Optogenetic silencing of nociceptive primary afferents reduces evoked and ongoing bladder pain. Sci. Rep. 20, 15865 (2017).
The authors declare no competing interests.
About this article
Cite this article
Grill, W.M., DeBerry, J.J. Innovative device illuminates the horizon of bioelectronic medicines. Nat Rev Urol 16, 209–210 (2019). https://doi.org/10.1038/s41585-019-0155-9